Business Management - Finance/Financial
Quad announced that it delivered a strong first quarter, despite reduction in near-term client demand due to the COVID-19 pandemic.
As part of the company's first-quarter 2020 financial results, Xerox reported a $49 million decrease in operating cash flow and $1.86 billion of revenue. The company is also producing FDA-approved ventilators, antiseptic hand sanitizer, and medical-grade face masks to help fight the COVID-19 pandemic.
Book and magazine printing powerhouse LSC Communications voluntarily filed for business reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York. The only surprise — perhaps expedited from the financial fallout of COVID-19 — is that the announcement came April 13.
As we struggle through the shelter-in-place pandemic and wonder how this will change business, there are two strategies in-plants should consider: increase the use of automation and cross-train staff to handle more tasks.
The coalition implores the members of congress to provide USPS with adequate emergency funding in the coronavirus relief package, warning that any less than $15 billion would be devastating.
COVID-19's effect on the economy has been profound. How this all plays out will depend on the economy’s underlying health and the effectiveness of support. Drawing on the resources of federal, state, and local agencies is important — there’s no reason to go it alone. Here are some suggestions for printers.
Heidelberg's management board has adopted a previously announced action package to reduce structural costs and improve profitability. The company plans to cease production on unprofitable businesses and reduce its global workforce by up to 2,000 jobs, among other strategic moves.
The Xerox offer undervalues HP and disproportionately benefits Xerox shareholders, Chip Bergh, chair of HP’s board of directors, said. It would leave HP shareholders with an investment in a combined company that is burdened with an irresponsible level of debt and unrealistic, unachievable synergies.
The ongoing skirmish between R.R. Donnelley & Sons and Chatham Asset Management, its largest bondholder, is turning into a war over a Poison Pill.
2020 promises to be as turbulent a year as the industry has ever witnessed, with both growth and recession on the minds of economists.